Valeant Eyeing Dermatology, Dentistry for M&A: CEO

March 19 (Bloomberg) -- Mike Pearson, chief executive officer of Valeant Pharmaceuticals International Inc., talks about the company's acquisition and growth strategy. He speaks with Stephanie Ruhle and Matt Miller on Bloomberg Television's "Market Makers." (Source: Bloomberg)
SpaceX Cracks the $70 Billion Military Market
26:31 - The U.S. Air Force's May 26 certification of SpaceX's Falcon 9 rocket means revenue could decline for a Lockheed-Boeing joint venture, United Launch Alliance, as the new competitor begins bidding for national-security satellite launches as soon as June. Bloomberg's Emily Chang has more on "Bloomberg West." (Source: Bloomberg)
  • Apple Pours Fuel on Speculation It's Working on a Car
  • An Avago-Broadcom Deal Would Be Chip Industry's Biggest
  • TiVo CEO: Our Secret to Growth Success